Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-disparate miniature swine

Transplantation

Volumn 65, Issue 3, 1998, Pages 304-313

  Madsen, Joren C ^a   Yamada, Kazuhiko ^a   Allan, James S ^a   Choo, Joseph K ^a   Erhorn, Angelique E ^a   Pins, Michael R ^a,b   Vesga, Liana ^a,c   Slisz, Joanna K ^a   Sachs, David H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART PROTECTION; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; INBRED STRAIN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; SWINE;

ANIMALS; CORONARY DISEASE; CORONARY VESSELS; CYCLOSPORINE; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; SWINE; SWINE, MINIATURE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA;

EID: 0032519430     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199802150-00002     Document Type: Article

References (47)

1. Uretsky BF, Murali S, Reddy S, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987; 76: 827.
2. Billingham ME. Graft coronary disease: the lesions and the patients. Transplant Proc 1989; 21: 3665.
3. Gao SZ, Schroeder JS, Alderman E, et al. Prevalence of accelerated coronary artery disease in heart transplant survivors: comparison of cyclosporin and azathioprine regimens. Circulation 1989; 80 (suppl III): III-100.
4. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
5. Sachs DH, Leight G, Cone J, Schwartz S, Stuart L, Rosenberg S. Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation 1976; 22: 559.
6. Madsen JC, Sachs DH, Fallon JT, Weissman NJ. Cardiac allograft vasculopathy in partially inbred miniature swine. J Thorac Cardiovasc Surg 1996; 111: 1230.
7. Rosengard BR, Ojikutu CA, Guzzetta PC, et al. Induction of specific tolerance to class I disparate renal allografts in miniature swine with cyclosporine. Transplantation 1992; 54: 490.
8. Pennington LR, Lunney JK, Sachs DH. Transplantation in miniature swine. VIII. Recombination within the major histocompatibility complex of miniature swine. Transplantation 1981; 31: 66.
9. Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P. Variations in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 1985; 57: 65.
10. Steinbrüchel DA, Nielsen B, Salomon S, Kemp E. A new model for heterotopic heart transplantation in rodents: graft atrial septectomy. Transplant Proc 1994; 26: 1298.
11. Kirkman RL, Colvin MW, Flye GS, et al. Transplantation in miniature swine. VI. Factors influencing survival of renal allografts. Transplantation 1979; 28: 18.
12. Billingham ME. Cardiac transplantation arteriosclerosis. Transplant Proc 1987; 19: 19.
13. Lurie KG, Billingham ME, Jamieson SW, Harrison DC, Reitz BA. Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model. Transplantation 1981; 31: 41.
14. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am J Pathol 1994; 144: 260.
15. Colvin RB. The renal allograft biopsy. Kidney Int 1996; 50: 1069.
16. Pescovitz MD, Thistlethwiate JR Jr, Auchincloss H Jr, et al. Effect of class II antigen matching on renal allograft survival in miniature swine. J Exp Med 1984; 160: 1495.
17. Colvin RB, Chase CM, Winn HJ, Russell PS. Chronic allograft arteriopathy: insights from experimental models. In: Orosz CG, Sedmak DD, Ferguson RM, eds. Transplant vascular solerosis. Austin, TX: R.G. Landes Co., 1995: 7.
18. Gianello P, Fishbein JM, Sachs DH. Tolerance to primarily vascularized allografts in miniature swine. Immunol Rev 1993; 133: 19.
19. Suciu-Foca N, Reed E, Marboe C, et al. The role of anti-HLA antibodies in heart transplantation. Transplantation 1991; 51: 716.
20. Reed EF, Hong B, Ho E, Harris PE, Weinberger J, Suciu-Foca N. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation 1996; 61: 566.
21. Bian H, Harris PE, Mulder A, Reed EF. Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tryosine phosphorylation, inositol phosphate generation, and proliferation. Hum Immunol 1997; 53: 90.
22. Allan JS, Choo JK, Vesga L, et al. Cardiac allograft vasculopathy is abrogated by anti-CD8 monoclonal antibody therapy. Ann Thorac Surg 1997; 64: 1019.
23. Russell PS, Chase CM, Colvin RB, Plate JMD. Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J Exp Med 1978; 147: 1449.
24. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.
25. Cramer DV. Cardiac transplantation: immune mechanisms and alloantigens involved in graft rejection. Crit Rev Immunol 1987; 7: 1.
26. Calne RY, Sells RA, Pena JR. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472.
27. Kamada N. Transplantation tolerance and immunosuppression following liver grafting in rats. Immunol Today 1985; 6: 336.
28. Narula J, Bennett LE, DiSalvo TG, Hosenpud JD, Semigran MJ, Dec GW. Outcomes in recipients of combined heart-kidney transplantation: multi-organ, same-donor transplant study of the International Society of Heart and Lung Transplantation/ United Network for Organ Sharing scientific registry. Transplantation 1997; 63: 861.
29. Yamada K, Gianello PR, Ierino FL, et al. Role of the thymus in transplantation tolerance in miniture swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I-mismatched renal allografts. J Exp Med 1997; 186: 497.
30. Madsen JC, Superina RA, Wood KJ, Morris PJ. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988; 332: 161.
31. Kirkman RL. Of swine and men: organ physiology in different species. In: Hardy MA, ed. Xenograft 25. Amsterdam: Elsevier, 1989: 125.
32. Muller D, Ellis S, Topol E. Experimental models of coronary restenosis. J Am Coll Cardiol 1992; 19: 418.
33. Fuster V, Badimon L, Badimon JJ, Ip JH, Chesebro JH. The porcine model for the understanding of thrombogenesis and atherogenesis. Mayo Clin Proc 1991; 66: 818.
34. Orloff MS, DeMara EM, Coppage ML, et al. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction. Transplantation 1995; 59: 282.
35. Shin YT, Adams DH, Wyner LR, Akalin E, Sayegh MH, Karnovsky MJ. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model. Transplantation 1995; 59: 1647.
36. Wood PJ, Roberts ISD, Yang C, Cossens IA, Bell EB. Prevention of chronic rejection by donor-specific blood transfusion in a new model of chronic cardiac allograft rejection. Transplantation 1996; 61: 1440.
37. Pescovitz MD, Sachs DH, Lunney JK, Hsu SM. Localization of class II MHC antigen on porcine renal vascular endothelium. Transplantation 1984; 37: 627.
38. Madsen JC, Wood KJ, Morris PJ. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. Transplantation 1987; 44: 849.
39. Pearson TC, Madsen JC, Larsen CP, Morris PJ, Wood KJ. Induction of transplantation tolerance in the adult using donor antigen and anti-CD4 monoclonal antibody. Transplantation 1992; 54: 475.
40. Choo JK, Seebach JD, Nickeleit V, et al. Species differences in the expression of major histocompatibility complex class II antigens on coronary artery endothelium: implications for cell-mediated xenoreactivity. Transplantation 1997; 64: 1315.
41. McManus BM, Horley KJ, Wilson JE, et al. Prominence of coronary arterial wall lipid in human heart allografts: implications for pathogenesis of allograft arteriopathy. Am J Pathol 1995; 147: 308.
42. Billingham ME. Chronic rejection in human allografts. In: Orosz CG, Sedmak DD, Ferguson RM, eds. Transplant Vascular Sclerosis. Austin, TX: R.G. Landes Co., 1995: 35.
43. Russell PS, Chase CM, Colvin RB. Accelerated atheromatous lesions in mouse hearts transplanted to apolipoprotein-E-deficient recipients. Am J Pathol 1996; 149(1): 91.
44. Valantine HA, Hoang K, Dai X, et al. Insulin resistance is a critical determinant of TXCAD: evidence from an isograft model of heart transplantation [Abstract]. J Heart Lung Transplant 1997; 16: 64.
45. Adams DH, Karnovsky MJ. Hypercholesterolemia does not exacerbate arterial intimal thickening in chronically rejecting rat cardiac allografts. Transplantation 1989; 21: 437.
46. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomologus monkeys. Transplantation 1995; 59: 256.
47. Wong W, Stranford SA, Morris PJ, Wood KJ. Retroviral gene transfer of a donor class I MHC gene to recipient bone marrow cells induces tolerance to alloantigens in vivo. Transplant Proc 1997; 29: 1130.